Digital Aria Co Ltd

HLB Therapeutics Co.,Ltd. is a biotechnology company based in Seongnam-si, South Korea, founded in 2000. It develops pharmaceutical products in South Korea and internationally, including GBT-201, which uses Thymosin beta for ophthalmic diseases such as dry eye syndrome and neurotrophic keratopathy, and OKN-007 for glioblastoma brain tumor. The company also wholesales vaccines and manufactures electrical and electronic components such as motors, pumps, and transformers. It was formerly known as G-treeBNT Co., Ltd. and changed its name to HLB Therapeutics Co.,Ltd. in December 2021.